Suppression of nuclear factor-kappaB activity in Kupffer cells protects rat liver graft from ischemia-reperfusion

J D Li1, Y Peng, X Y Peng

  • 1Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, China.

Abstract

Insights

Nuclear factor-kappaB (NF-κB) decoy oligodeoxynucleotides (ODN) protect rat liver grafts from ischemia-reperfusion injury (IRI). This strategy suppresses NF-κB activation and reduces inflammatory cytokine production, preserving liver function.

Area of Science:

  • Hepatology
  • Transplantation Immunology
  • Molecular Biology

Background:

  • Ischemia-reperfusion injury (IRI) is a significant complication in liver transplantation.
  • Nuclear factor-kappaB (NF-κB) activation in Kupffer cells (KCs) contributes to IRI pathogenesis.
  • Targeting NF-κB offers a potential therapeutic strategy for liver graft protection.

Purpose of the Study:

  • To investigate the protective effects of NF-κB decoy oligodeoxynucleotides (ODN) on rat liver grafts subjected to IRI.
  • To elucidate the underlying mechanisms of NF-κB decoy ODN in mitigating IRI.

Main Methods:

  • Rats were allocated to control, IRI, and NF-κB decoy ODN treatment groups.
  • Donor liver grafts were transfected with NF-κB decoy ODN prior to procurement.
  • NF-κB binding activity, TNF-α and IL-6 mRNA expression, and liver function tests were assessed post-reperfusion.

Main Results:

  • IRI significantly increased NF-κB activity, pro-inflammatory cytokine mRNA (TNF-α, IL-6), and markers of liver damage (ALT, bilirubin).
  • Hepatocyte degeneration and necrosis were observed in IRI group.
  • NF-κB decoy ODN treatment significantly ameliorated these IRI-induced changes, preserving liver architecture.

Conclusions:

  • KC NF-κB activation is a key mediator of IRI in liver transplantation.
  • NF-κB decoy ODN effectively suppresses NF-κB activation and downstream cytokine production.
  • This decoy strategy demonstrates significant protective effects against liver graft IRI.